首页> 外国专利> THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING C-MET AUTOPHOSPHORYLATION INHIBITING POTENCY

THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING C-MET AUTOPHOSPHORYLATION INHIBITING POTENCY

机译:硫代吡啶衍生物或喹啉衍生物或喹唑啉衍生物,具有C-MET自磷酸化抑制能力

摘要

An objective of the present invention is to provide compounds having antitumor activity. According to the present invention, there is provided compounds represented by formula (I) and pharmaceutically acceptable salts thereof, and solvates thereof: wherein R 1 represents H or a substitutable unsaturated five- or six-membered heterocyclic ring; R 2 represents H; X represents CH or N; Z represents O or S; E is absent or represents halogen, alkyl, or alkoxy; J represents S or O; and T represents phenyl, an unsaturated five- or six-membered heterocyclic ring, an unsaturated nine- or ten-membered bicyclic carbocyclic ring or heterocyclic ring.
机译:本发明的目的是提供具有抗肿瘤活性的化合物。根据本发明,提供了由式(I)表示的化合物及其药学上可接受的盐及其溶剂化物:其中R 1代表H或可取代的不饱和五元或六元杂环; R 2代表H; X代表CH或N; Z代表O或S; E不存在或代表卤素,烷基或烷氧基; J代表S或O; T表示苯基,不饱和五元或六元杂环,不饱和九元或十元双环碳环或杂环。

著录项

  • 公开/公告号EP1870414A4

    专利类型

  • 公开/公告日2010-01-06

    原文格式PDF

  • 申请/专利权人 KIRIN PHARMA KABUSHIKI KAISHA;

    申请/专利号EP20060730282

  • 申请日2006-03-28

  • 分类号C07D495/04;A61K31/4365;A61K31/437;A61K31/47;A61K31/4709;A61K31/5377;A61P35;C07D215/233;C07D401/12;C07D471/04;

  • 国家 EP

  • 入库时间 2022-08-21 18:38:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号